NO20006128D0 - Nye substituerte (dihydro) benzoksazin- og (dihydro) benzotiazinforbindelser, en fremgangsmåte ved deres fremstilling og farmasöytiske sammensetning inneholdende dem - Google Patents

Nye substituerte (dihydro) benzoksazin- og (dihydro) benzotiazinforbindelser, en fremgangsmåte ved deres fremstilling og farmasöytiske sammensetning inneholdende dem

Info

Publication number
NO20006128D0
NO20006128D0 NO20006128A NO20006128A NO20006128D0 NO 20006128 D0 NO20006128 D0 NO 20006128D0 NO 20006128 A NO20006128 A NO 20006128A NO 20006128 A NO20006128 A NO 20006128A NO 20006128 D0 NO20006128 D0 NO 20006128D0
Authority
NO
Norway
Prior art keywords
alkyl
dihydro
nrr
benzoxazine
halo
Prior art date
Application number
NO20006128A
Other languages
English (en)
Other versions
NO20006128L (no
NO317991B1 (no
Inventor
Marie-Claude Viaud
Gerald Guillaumet
Philippe Daubos
Caroline Bennejean
Philippe Delagrange
Pierre Renard
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of NO20006128D0 publication Critical patent/NO20006128D0/no
Publication of NO20006128L publication Critical patent/NO20006128L/no
Publication of NO317991B1 publication Critical patent/NO317991B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Psychology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20006128A 1999-12-06 2000-12-01 Nye substituerte (dihydro) benzoksazin- og (dihydro) benzotiazinforbindelser, en fremgangsmate ved deres fremstilling og farmasoytiske sammensetning inneholdende dem NO317991B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9915309A FR2801885B1 (fr) 1999-12-06 1999-12-06 Nouveaux derives (dihydro)benzoxaziniques et (dihydro) benzothiaziniques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (3)

Publication Number Publication Date
NO20006128D0 true NO20006128D0 (no) 2000-12-01
NO20006128L NO20006128L (no) 2001-06-07
NO317991B1 NO317991B1 (no) 2005-01-17

Family

ID=9552901

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006128A NO317991B1 (no) 1999-12-06 2000-12-01 Nye substituerte (dihydro) benzoksazin- og (dihydro) benzotiazinforbindelser, en fremgangsmate ved deres fremstilling og farmasoytiske sammensetning inneholdende dem

Country Status (22)

Country Link
US (1) US6620809B2 (no)
EP (1) EP1106608B1 (no)
JP (1) JP3572012B2 (no)
KR (1) KR100491601B1 (no)
CN (1) CN1147482C (no)
AT (1) ATE233744T1 (no)
AU (1) AU774186B2 (no)
BR (1) BR0005736A (no)
CA (1) CA2328553A1 (no)
DE (1) DE60001534T2 (no)
DK (1) DK1106608T3 (no)
EA (1) EA004762B1 (no)
ES (1) ES2193926T3 (no)
FR (1) FR2801885B1 (no)
HU (1) HUP0004837A2 (no)
MX (1) MX223546B (no)
NO (1) NO317991B1 (no)
NZ (1) NZ508631A (no)
PL (1) PL344300A1 (no)
SI (1) SI1106608T1 (no)
TR (1) TR200300359T4 (no)
ZA (1) ZA200007214B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1735603A (zh) * 2002-12-06 2006-02-15 东丽株式会社 苯并吗啉衍生物
FR2853649B1 (fr) * 2003-04-09 2006-07-14 Servier Lab Nouveaux derives d'isoquinoleine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CL2008001563A1 (es) * 2007-05-30 2008-10-10 Wyeth6 3 Compuestos derivados de benzodioxanos condensados con heterociclos; metodo de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como depresion, ansiedad, crisis de panico, entre otras.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1173942A (en) * 1967-06-06 1969-12-10 Bellon Labor Sa Roger New 2,3-Dihydro-1,4-Benzoxazines
CA2035147A1 (en) * 1990-02-08 1991-08-09 Kousuke Yasuda Thiazine (or oxazine) derivatives and preparation thereof
PL343317A1 (en) * 1998-03-31 2001-08-13 Warner Lambert Co Benzoxazinones/benzothiazinones as serine protease inhibitors

Also Published As

Publication number Publication date
SI1106608T1 (en) 2003-06-30
KR100491601B1 (ko) 2005-05-27
MXPA00011967A (es) 2002-05-23
HUP0004837A2 (hu) 2002-04-29
FR2801885B1 (fr) 2002-01-11
NO20006128L (no) 2001-06-07
EA200001157A3 (ru) 2001-08-27
ES2193926T3 (es) 2003-11-16
JP3572012B2 (ja) 2004-09-29
US20010003747A1 (en) 2001-06-14
CN1308069A (zh) 2001-08-15
DK1106608T3 (da) 2003-06-02
PL344300A1 (en) 2001-06-18
CN1147482C (zh) 2004-04-28
ZA200007214B (en) 2001-06-06
FR2801885A1 (fr) 2001-06-08
DE60001534D1 (de) 2003-04-10
JP2001187787A (ja) 2001-07-10
EP1106608B1 (fr) 2003-03-05
AU774186B2 (en) 2004-06-17
CA2328553A1 (fr) 2001-06-06
EP1106608A1 (fr) 2001-06-13
EA004762B1 (ru) 2004-08-26
MX223546B (es) 2004-10-19
HU0004837D0 (no) 2001-02-28
BR0005736A (pt) 2001-07-17
DE60001534T2 (de) 2004-01-08
EA200001157A2 (ru) 2001-06-25
ATE233744T1 (de) 2003-03-15
US6620809B2 (en) 2003-09-16
AU7207300A (en) 2001-06-07
KR20010062170A (ko) 2001-07-07
TR200300359T4 (tr) 2004-02-23
HK1038741A1 (en) 2002-03-28
NO317991B1 (no) 2005-01-17
NZ508631A (en) 2002-03-01

Similar Documents

Publication Publication Date Title
DE69428476D1 (de) Heterocyclische Verbindungen als Bradykinin Antagonisten
NO995175D0 (no) Nye dihydro- og tetrahydrokinolinforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
EP1389617A4 (en) Heterocyclic compound and antitumor agent containing it as an active ingredient
ATE356117T1 (de) Derivate des n-((chinolinyl)oxy)-phenyl)- harnstoffs und des n-((chinazolinyl)oxy)-phenyl)- harnstoffs mit antitumor aktivität
AU2464997A (en) New 3-(piperid-4-YL)-1,2-benzisoxazole and 3-piperazin-4-YL)-1,2-benzisoxazole compounds, processes for their preparation and pharmaceutical compositions containing them
HUT40668A (en) Process for preparing new benzoxazole and amine derivatives and pharmaceutical compositions containing such compounds
AU3113793A (en) Intermediates for preparing antipicornaviral pyridazinamines
IL113778A (en) Condensed-indan derivatives pharmaceutical compositions containing the same and methods for the preparation thereof
DE60214401D1 (de) Hetero-bicyclische crf antagonisten
AU6785201A (en) Novel pyrazinone derivatives
NO20006128D0 (no) Nye substituerte (dihydro) benzoksazin- og (dihydro) benzotiazinforbindelser, en fremgangsmåte ved deres fremstilling og farmasöytiske sammensetning inneholdende dem
CA2254755A1 (en) Hexahydro-pyrido(4,3-b)indole derivatives as antipsychotic drugs
ZA200006912B (en) Dihydrofuro[3,4-B]Quinolin-1-one compounds, a process for their preparation and pharmaceutical compositions containing them.
CA2203850A1 (en) Novel n-phenyl-n-phenyliminonethylbenzamidines and their analogues as muscarinic receptor agonists
HUT38649A (en) Process for preparing pyrimido/2,1-b/benzothiazole derivatives and pharmaceutical compositions containing such compounds as active substances
NO20002940L (no) Nye forbindelser av 7-okso-2,3,7,14-tetrahydro-1H-benzo- [b]pyrano[3,2-h]akridinkarboksylat, en fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
AU3017397A (en) New bisimide compounds, process for preparing them and pharmaceutical compositions containing them
EA200200379A2 (ru) Новые соединения пиримидин-4-она, способ их получения и содержащие их фармацевтические композиции
NO996285D0 (no) Nye spiroimidazolinforbindelser, fremgangsmåte ved deres fremstilling og farmasoeytiske sammensetninger inneholdende dem
HU9600597D0 (en) 4-alkylthio-pyrimidin-5-yl acetic acid derivates and fungicidal compositions containing them as an active ingredient
HUT65376A (en) Process for preparing n,n',n-trisubstituted 5-(diamino-methylene)-1,3-dioxane-4,6-diones and pharmaceutical compositions containing them as active ingredient
ZA987076B (en) Bis-pyrido[4,3-b]carbazole compounds a process for their preparation and pharmaceutical compositions containing them